Trial Profile
Phase II trial of ZP 1848 in patients with Crohn's disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2010
Price :
$35
*
At a glance
- Drugs Glepaglutide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Zealand Pharma
- 18 Oct 2010 New trial record